RVP · Retractable Technologies Inc
$0.73
0.00 (-0.67%)
At close · Aug 26
Market Cap
$21.85M
Shares
29.94M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$38.27M
+15.8%
FY2025
Net Income
-$12.57M
-5.7%
FY2025
Gross Margin
0.12%
+3.2pp
FY2025
Operating Margin
-55.34%
+8.5pp
FY2025
Diluted EPS
-$0.43
-7.5%
FY2025
Operating Cash Flow
-$7.06M
+38.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $33.9M | $38.27M | $33.05M | $43.6M | $94.82M | $188.38M | $81.86M | $41.8M | $33.27M | $34.49M | $29.83M | $29.55M | $34.52M | $30.79M | $33.64M | $32.1M | $36.22M | $38.98M | |
| $34.39M | $38.22M | $34.08M | $34.49M | $66.57M | $93.03M | $44.85M | $27.66M | $23.05M | $24.52M | $19.48M | $18.99M | $22.5M | $20.48M | $22.47M | $21.2M | $23.7M | $25.47M | |
| -$491.51K | $47.05K | -$1.03M | $9.11M | $28.25M | $95.35M | $37.01M | $14.14M | $10.22M | $9.97M | $10.34M | $10.57M | $12.02M | $10.31M | $11.18M | $10.9M | $12.52M | $13.52M | |
| — | 0.12% | -3.11% | 20.89% | 29.8% | 50.62% | 45.21% | 33.83% | 30.72% | 28.91% | 34.67% | 35.75% | 34.82% | 33.49% | 33.22% | 33.96% | 34.57% | 34.67% | |
| $682.03K | $675.57K | $673.94K | $581.17K | $525.73K | $901.38K | $574.53K | $516.1K | $621.37K | $740.57K | $571.84K | $607.53K | $616.78K | $837.07K | $871.85K | $815.02K | $885.45K | $1.03M | |
| $6.83M | $6.82M | $5.85M | $5.71M | $4.54M | $4.48M | $4.06M | $4.22M | $4.4M | $4.66M | $4.03M | $3.84M | $3.97M | $4.41M | $4.22M | $3.44M | $3.67M | $4.37M | |
| $13.73M | $12.77M | $13.56M | $14.31M | $24.04M | $17.38M | $8.3M | $6.43M | $6.79M | $8.35M | $8.8M | $9.33M | $9.6M | $10.99M | $10.02M | $10.74M | $14.26M | $18.81M | |
| — | — | — | — | — | — | — | — | — | — | — | $8587 | $9272 | $11.48K | $71.53K | $43.93K | $43.44K | — | |
| — | $7.77M | $7.57M | $7.53M | $4.6M | $1.26M | $832.07K | $852.08K | $886.81K | $834.95K | $872.87K | $858.39K | $1.07M | $1.28M | $1.34M | $1.31M | $1.52M | $1.4M | |
| $22.19M | $21.22M | $20.08M | $20.6M | $29.11M | $22.76M | $12.94M | $11.17M | $11.81M | $13.75M | $13.85M | $13.77M | $14.18M | $16.24M | $15.12M | $14.99M | $19.19M | $26.81M | |
| -$22.68M | -$21.18M | -$21.11M | -$11.49M | -$852.98K | $72.6M | $24.07M | $2.97M | -$1.33M | -$3.78M | -$3.51M | -$3.21M | -$2.16M | -$5.93M | -$3.94M | -$4.09M | -$6.66M | -$13.3M | |
| — | -55.34% | -63.86% | -26.35% | -0.9% | 38.54% | 29.4% | 7.11% | -4% | -10.95% | -11.76% | -10.85% | -6.25% | -19.27% | -11.71% | -12.74% | -18.4% | -34.11% | |
| — | -$13.41M | -$13.54M | -$3.96M | $3.75M | $73.85M | $24.9M | $3.82M | -$442.72K | -$2.94M | -$2.63M | -$2.35M | -$1.08M | -$4.65M | -$2.6M | -$2.78M | -$5.15M | -$11.9M | |
| $81.34K | $87.9K | $122.5K | $152.17K | $170.65K | $227.18K | $260.26K | $166.9K | $177.19K | $210.76K | $213.3K | $219.67K | $222.81K | $230.58K | $231.21K | $240.48K | $302.84K | $21.89K | |
| -$3.36M | -$12.27M | -$3.52M | -$8.92M | $5.16M | $74.95M | $26.07M | $3.16M | -$1.35M | -$3.92M | -$3.69M | $4.32M | -$2.35M | -$6.12M | -$4.12M | $1.43M | $2.22M | -$13.26M | |
| $7392 | $291.29K | $8.37M | -$1.91M | $83.87K | $18.89M | $1.85M | $7875 | -$13.32K | -$187.61K | $1132 | $7877 | $8177 | $90.97K | $9818 | $13.8K | -$176.06K | -$3.84M | |
| -$3.37M | -$12.57M | -$11.89M | -$7.01M | $5.08M | $56.06M | $24.22M | $3.15M | -$1.34M | -$3.74M | -$3.69M | $4.31M | -$2.35M | -$6.21M | -$4.13M | $1.42M | $2.4M | -$9.42M | |
| — | -32.84% | -35.97% | -16.08% | 5.36% | 29.76% | 29.59% | 7.53% | -4.03% | -10.83% | -12.39% | 14.6% | -6.82% | -20.18% | -12.28% | 4.42% | 6.63% | -24.17% | |
| -$3.6M | -$12.8M | -$12.12M | -$7.24M | $4.85M | $55.82M | $26.62M | $2.45M | -$2.04M | -$4.44M | -$4.4M | $5.91M | -$3.27M | -$7.13M | -$5.05M | $454.44K | $1.03M | -$10.79M | |
| USD/shares | -$0.13 | -$0.43 | -$0.40 | -$0.24 | $0.15 | $1.65 | $0.80 | $0.07 | -$0.06 | -$0.14 | -$0.15 | $0.21 | -$0.12 | -$0.26 | -$0.19 | $0.02 | $0.04 | -$0.45 |
| USD/shares | -$0.13 | -$0.43 | -$0.40 | -$0.24 | $0.15 | $1.63 | $0.80 | $0.07 | -$0.06 | -$0.14 | -$0.15 | $0.20 | -$0.12 | -$0.26 | -$0.19 | $0.02 | $0.04 | -$0.45 |
| shares | — | 29.94M | 29.94M | 29.94M | 32.9M | 33.87M | 33.17M | 32.67M | 32.67M | 31.96M | 29.35M | 27.82M | 27.38M | 27M | 26.22M | 24.17M | 23.87M | 23.81M |
| shares | — | 29.94M | 29.94M | 29.94M | 32.96M | 34.24M | 33.3M | 32.67M | 32.67M | 31.96M | 29.35M | 29.48M | 27.38M | 27M | 26.22M | 26.35M | 26.25M | 23.81M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2012–FY2022: $13.99M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.57×
Peer median 1.04×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 12 similar-size Medical Instruments & Supplies companies (of 45 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Single Reportable Segment | $38,266,211 | $33,049,533 | $43,596,926 | — | — | — |
| Customers in North and South America Excluding United States | — | — | — | $29,126,820 | $14,561,236 | $6,893,150 |
| International Customers Excluding North and South America | — | — | — | $13,468,707 | $6,270,642 | $1,165,497 |
| U.S. Government | — | — | — | $15,731,136 | $113,662,440 | $31,634,343 |
| United States Customers Excluding United States Government | — | — | — | $36,492,275 | $53,888,136 | $42,169,463 |
By Geography (USD)
| Component | FY2021 | FY2020 | FY2019 |
|---|---|---|---|
| U.S. Government | $113,662,440 | $31,634,343 | — |
| United States | $53,888,136 | $42,169,463 | $31,897,924 |
| Americas | $14,561,236 | $6,893,150 | $8,248,990 |
| Other International | $6,270,642 | $1,165,497 | $1,650,265 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Syringes | $24,909,956 | $22,629,888 | $34,155,340 | $86,738,861 | $176,330,309 | $68,731,795 | $35,638,427 |
| EasyPoint Needles | $11,942,637 | $8,948,186 | $7,248,742 | $4,674,278 | $9,636,440 | $9,629,173 | $2,979,005 |
| Blood Collection Products | $1,369,991 | $1,425,607 | $1,926,571 | $2,953,849 | $2,248,150 | $2,363,887 | $2,715,697 |
| Other Products | $43,627 | $45,852 | $266,273 | $451,950 | $167,555 | $1,137,598 | $464,050 |
| License | — | $189,000 | $778,000 | — | — | — | — |